China Phase II Clinical Study of Osemitamab Completes Enrollment for First-Line Gastric Cancer Treatment

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

May 03, 2023 | Wednesday | News
BVI Announces Complete Enrollment of FINEVISION® HP IDE Clinical Study

The milestone marks the final implantation of the 539th patient enrolled in the prospective, multicenter, randomized, masked, controlled IDE clinical study...

May 02, 2023 | Tuesday | News
Aurora Expands Medical Cannabis Portfolio in Germany

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer a...

May 01, 2023 | Monday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
UCLA Health and CHOC collaborate to enhance access to pediatric congenital cardiac care

"Our shared vision is one program offered at two sites to provide patients with the right care in a location close to home," said Dr. Glen Van Arsdell, who...

April 28, 2023 | Friday | News
Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease

European Commission Approval of Opfolda and Commercial Launch of Pombiliti® + Opfolda® Anticipated in 3Q 2023   Upon Approval, Pombiliti + O...

April 27, 2023 | Thursday | News
Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...

April 26, 2023 | Wednesday | News
QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use ...

April 25, 2023 | Tuesday | News
NICO Corporation's Positive Surgical Trial for Deadly Stroke Type is World's First

Currently, up to 50% of people die within 30 days of an ICH, Highlighting the Need for New Options1    NICO Corporation, a pioneer and lea...

April 24, 2023 | Monday | News
Zylox-Tonbridge Forms Strategic Partnership with Hicicare for Innovative Chinese Vascular Guidewire Solutions

With the collaboration, Zylox Medical, the Company's peripheral vascular business unit, plans to launch the "Zylox-Hicicare Guidewire Family" products to a...

April 24, 2023 | Monday | News
FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology and 5-Minute Auto Corrections.

 Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its Mini...

April 22, 2023 | Saturday | News
Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applyin...

April 21, 2023 | Friday | News
AbbVie Presents Late-Breaking Atogepant Phase 3 Results for Episodic Migraine Treatment at 2023 AAN Meeting.

The Phase 3 ELEVATE study demonstrated atogepant is effective and well-tolerated for the preventive treatment of episodic migraine in people who previous...

April 21, 2023 | Friday | News
Segmed, NVIDIA, and RadImageNet Kickstart Generative AI Initiative for Synthetic Medical Imaging Data

As part of this initiative, Segmed will offer synthetic medical imaging data on their self-serve medical data curation platform, Segmed Insight. This is in...

April 20, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close